Paradigm Biopharmaceuticals Limited

Ticker PAR

Exchange ASX More
Industry Biotechnology More
Sector Healthcare More

1-10 Employees
Based in Melbourne, Australia

Paradigm Biopharmaceuticals Limited, a drug repurposing company, engages in the research and development of therapeutic products for human use in Australia. It offers pentosan polysulphate sodium drugs in the injectable form for the treatment of bone marrow edema lesions, osteoarthritis, mucopolysaccharidosis, and alphaviral arthritis diseases. The company was incorporated in 2014 and is…More

Visit website

REPORT RATINGS

4.8 / 5.0 (83)

Paradigm Biopharmaceuticals Limited reports have an aggregate usefulness score of 4.8 based on 83 reviews.

Paradigm Biopharmaceuticals Limited